Get started
Author

Deborah Rodriguez

Observed name: D. Rodriguez
ORCID: 0000-0003-0209-0612
Observed ORCID: 0000-0003-0209-0612
OpenAlex ID: A5055423852
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
2022 · Juan Ibarra, Yassmin A. Elbanna, et al. · Blood Cancer Discovery · 43
PDF
CDK9 activity switch associated with AFF1 and HEXIM1 controls differentiation initiation from epidermal progenitors
2022 · Sarah M. Lloyd, Daniel B. Leon, et al. · Nature Communications · 14
PDF
Abstract LB256: Type 1 calreticulin mutations in myeloproliferative neoplasms promote glycolysis via intracellular calcium mediated upregulation of GLUT1
2023 · Michele Ciboddo, Jonathan Dowgielewicz, et al. · Cancer Research
Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
2023 · Juan Ibarra, Yassmin A. Elbanna, et al.
Supplementary Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
2023 · Juan Ibarra, Yassmin A. Elbanna, et al.
PDF
Supplementary Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
2023 · Juan Ibarra, Yassmin A. Elbanna, et al.
460 Rapid activation of epidermal progenitor differentiation via CDK9 activity modulated by AFF1 and HEXIM1
2022 · S. Lloyd, M. Brady, et al. · Journal of Investigative Dermatology
Abstract LB134: Type 1 calreticulin mutations differentially activate the IRE1α-XBP1 pathway of the unfolded protein response to drive myeloproliferative neoplasms
2022 · Juan Ibarra, Yassmin Elbanna, et al. · Cancer Research
Works count: 8
Citation count: 57
H-index: 2
I10-index: 2
Year
Topic
Type